Sydney Medical School, University of Sydney, Sydney, NSW, Australia.
Alcohol and Drug Services, St Vincent's Hospital, Sydney, NSW, Australia.
Med J Aust. 2013 Dec 16;199(11):759-61. doi: 10.5694/mja13.10728.
• After considering extensive scientific and medical evidence, a New South Wales Legislative Council multiparty committee recommended that medicinal cannabis should lawfully be made available for selected-use pharmacotherapy. • The evidence indicates that cannabis has genuine medicinal utility in patients with certain neuropathic conditions, with acceptable levels of risk from mostly mild side effects. • The potential medical benefits of cannabis pharmacotherapy have largely been overlooked, with research and society's attention, in most parts of the world, being directed towards the hazards of its recreational use. • The NSW Government has since dismissed the unanimous and compassionate recommendations of their committee.
• 在考虑了广泛的科学和医学证据后，新南威尔士州立法委员会的一个多党派委员会建议，应合法提供药用大麻供特定用途的药物治疗。 • 证据表明，大麻对某些神经病变患者具有真正的药用功效，且其副作用主要为轻度，风险可接受。 • 药用大麻疗法的潜在医学益处在很大程度上被忽视了，在世界大部分地区，研究和社会的注意力都集中在其娱乐用途的危害上。 • 此后，新南威尔士州政府驳回了该委员会一致且富有同情心的建议。
